You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AVEO

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Houston (177Lu rhPSMA-10.1, Degarelix)

Not yet recruiting
  • Prostate Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)

Withdrawn
  • Stage II Renal Cell Cancer
  • Stage III Renal Cell Cancer
  • (no location specified)
Aug 11, 2022

Pancreatic Cancer Trial in Boston (Gemcitabine, Nab-paclitaxel, Ficlatuzumab)

Completed
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Aug 1, 2021

Solid Tumors Trial in Worldwide (Tivozanib + paclitaxel, Tivozanib + temsirolimus, Tivozanib)

Terminated
Has Results
  • Solid Tumors
  • Tivozanib + paclitaxel
  • +5 more
  • Scottsdale, Arizona
  • +48 more
Aug 17, 2020

Advanced Adult Hepatocellular Carcinoma, Non-Resectable Hepatocellular Carcinoma Trial in Buffalo, Cleveland (Tivozanib (1mg),

Completed
Has Results
  • Advanced Adult Hepatocellular Carcinoma
  • Non-Resectable Hepatocellular Carcinoma
  • Tivozanib (1mg)
  • Tivozanib (1.5mg)
  • Buffalo, New York
  • +1 more
Oct 6, 2020

Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in San Francisco (Ficlatuzumab,

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 22, 2020

Cachexia Trial (AV-380)

Not yet recruiting
  • Cachexia
  • AV-380
  • (no location specified)
May 9, 2023

Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

Not yet recruiting
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Ficlatuzumab
  • +2 more
  • (no location specified)
Sep 26, 2023

Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in United

Completed
Has Results
  • Recurrent Adult Soft Tissue Sarcoma
  • +2 more
  • Chicago, Illinois
  • +4 more
Aug 26, 2019

Hepatocellular Carcinoma Trial in United States (Tivozanib, Durvalumab)

Recruiting
  • Hepatocellular Carcinoma
  • Gilbert, Arizona
  • +11 more
Sep 2, 2021

Carcinoma, Renal Cell Trial in France (Tivozanib, Nivolumab)

Completed
  • Carcinoma, Renal Cell
  • Bordeaux, France
  • +3 more
Dec 2, 2021

Cachexia Trial in Newark (AV-380, Placebo)

Active, not recruiting
  • Cachexia
  • Newark, New Jersey
    Biotrial Inc.
Jan 18, 2022

Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +190 more
Jan 18, 2022

Carcinoma, Squamous Cell of Head and Neck, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head And Neck

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +2 more
  • Pittsburgh, Pennsylvania
  • +2 more
Apr 16, 2019

Triple Negative Breast Cancer Trial in Worldwide (Tivozanib Hydrochloride, paclitaxel, Placebo)

Terminated
Has Results
  • Triple Negative Breast Cancer
  • Tivozanib Hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +53 more
Oct 5, 2020

NSCLC Trial in Worldwide (Ficlatuzumab, Erlotinib, )

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Fresno, California
  • +46 more
Oct 20, 2020

Metastatic Renal Cell Carcinoma Trial in Worldwide (Tivozanib, Sunitinib)

Terminated
Has Results
  • Metastatic Renal Cell Carcinoma
  • Los Angeles, California
  • +37 more
Oct 5, 2020

Renal Cell Carcinoma Trial in Canada, United States (Tivozanib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Mobile, Alabama
  • +24 more
Oct 5, 2020

Acute Myeloid Leukemia Trial (Ficlatuzumab, Cytarabine)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
Mar 27, 2020

Carcinoma, Renal Cell Trial in India, Russian Federation, Ukraine (Tivozanib (AV-951), Placebo comparator)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Tivozanib (AV-951)
  • Placebo comparator
  • Vellore, Tamil Nadu, India
  • +25 more
Aug 17, 2020

Advanced Renal Cell Carcinoma Trial in Worldwide (Tivozanib, Sorafenib)

Completed
Has Results
  • Advanced Renal Cell Carcinoma
  • Los Angeles, California
  • +74 more
Sep 11, 2020

Advanced Renal Cell Carcinoma Trial in Worldwide (tivozanib (AV-951), Sorafenib)

Completed
Has Results
  • Advanced Renal Cell Carcinoma
  • Los Angeles, California
  • +85 more
Oct 7, 2019

Carcinoma, Squamous Cell of Head and Neck Trial in Pittsburgh (Ficlatuzumab, Cisplatin, Intensity Modulated Radiotherapy (IMRT))

Terminated
  • Carcinoma, Squamous Cell of Head and Neck
  • Pittsburgh, Pennsylvania
  • +2 more
Nov 8, 2017

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Boston (Tivozanib)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 4, 2017